UCB's Global Corporate Website

It’s World Lupus Day

Posted by
Kristel Santens, New Product Planning & Portfolio Management
<iframe width="100%" height="244" src="http://www.youtube.com/embed/5_NgvgQYrOY" frameborder="0" allowfullscreen></iframe>

Today is World Lupus Day, an opportunity to raise awareness of a severe disease which affects between 20 and 70 people per 100,0001 . At UCB, we’re investing in research in an effort to support people with lupus.

Systemic lupus erythematosus (SLE) is a severe chronic autoimmune disease in which body's defence mechanism begins to attack its own healthy organs. It is more common in women than in men. In fact, women of child-bearing age are nine times more likely than men of the same age to develop the disease1 .

Managing symptoms – which include extreme fatigue, headaches, painful joints and fever – is a priority for patients. And it’s a priority for us at UCB.

Our research has led to the development of a monoclonal antibody which is currently in clinical trials and being evaluated as a treatment for lupus.

1. Pons-Estel GJ, Alarcon GS, Scofield L, et al., Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010;39:257-68.

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.


Enter the characters shown in the image.